July 16, 2025 — Medtronic has announced that the first patient has been enrolled in the PEripheral Onyx Liquid Embolic (PELE) clinical trial, which will evaluate the safety and effectiveness of the ...
Cardiovascular Clinical Studies
This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.
-
-
May 27, 2025 — Despite scientific advances in cardiovascular care, people in living in rural areas and other communities with long-term economic or social challenges still face barriers to cutting ...
-
May 20, 2025 — Shockwave Medical, Inc., part of Johnson & Johnson MedTechhas announced the 30-day primary endpoint results of EMPOWER CAD, the first prospective, real-world percutaneous coronary ...
-
The American Heart Association recently announced that Dr. Christine E. Seidman, an internationally renowned physician-scientist and pioneer in cardiovascular genetics, has been selected as the ...
Aug. 4, 2025 — Marea Therapeutics, Inc., a clinical-stage biotechnology company that develops next-generation medicines ...
August 04, 2025
July 16, 2025 — Medtronic has announced that the first patient has been enrolled in the PEripheral Onyx Liquid Embolic ...
July 22, 2025
July 7, 2025 — Medtronic announced that it has treated the first patient in its SPYRAL GEMINI Pilot program (including ...
July 07, 2025
June 11, 2025 — Bayer and the Broad Institute have have extended their research collaboration of 10 years by an ...
June 11, 2025
May 27, 2025 — Despite scientific advances in cardiovascular care, people in living in rural areas and other communities ...
May 27, 2025
May 20, 2025 — Shockwave Medical, Inc., part of Johnson & Johnson MedTechhas announced the 30-day primary endpoint ...
May 21, 2025
The American Heart Association recently announced that Dr. Christine E. Seidman, an internationally renowned physician ...
May 02, 2025
Jan. 13, — A new cohort study among 103,642 adults found that current use of cigars was associated with increased risk ...
January 14, 2025
Nov. 22, 2024 — BridgeBio Pharma, Inc. recently announced that the U.S. Food and Drug Administration (FDA) approved ...
November 25, 2024
Nov. 18, 2024 — Silence Therapeutics presented end-of-treatment data from its Phase 2 ALPACAR-360 study of zerlasiran, a ...
November 18, 2024Aug. 23, 2024 — A team led by researchers at Yale School of Medicine has created a deep learning model that can accurate ...
August 26, 2024Aug. 15, 2024 — According to a new study being presented at ACC Asia 2024 in Delhi, India, drinking over 400 mg of ...
August 14, 2024
July 31, 2024 — A novel study co-authored by a heart failure cardiologist at University Hospitals Harrington Heart & ...
July 31, 2024
As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits ...
July 30, 2024
July 30, 2024 — Patients with congestive heart failure (CHF) having a compromised blood supply, are at greater risk of ...
July 30, 2024